{"disease":{"id":"lateral-sclerosis","name":"lateral sclerosis"},"drugs":{"marketed":[{"drug_id":"tofersen","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qalsody","generic_name":"TOFERSEN","company_name":"Biogen Ma","drug_phase":"marketed","molecular_target":"Superoxide dismutase 1 (SOD1) mRNA","drug_class":"Antisense Oligonucleotide [EPC]","quality_score":10,"revenue":"200","mechanism":"Qalsody works by binding to the messenger RNA (mRNA) of the Superoxide dismutase 1 (SOD1) gene, preventing its expression and reducing the production of the toxic SOD1 protein associated with ALS."},{"drug_id":"riluzole","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rilutek","generic_name":"RILUZOLE","company_name":"Covis","drug_phase":"marketed","molecular_target":"Sodium-dependent noradrenaline transporter","drug_class":"Benzothiazole [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"riltozinameran-12-years-of-age-and-older","indication_name":"Amyotrophic lateral sclerosis (ALS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Riltozinameran 12 Years of age and older","generic_name":"riltozinameran-12-years-of-age-and-older","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":34,"revenue":null,"mechanism":"Mechanism of action is not specified on Wikipedia."},{"drug_id":"neurontin","indication_name":"Seizures associated with amyotrophic lateral sclerosis (ALS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurontin","generic_name":"Gabapentin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"α2δ subunit of voltage-activated calcium channels","drug_class":"Antiepileptic/Analgesic","quality_score":10,"revenue":null,"mechanism":"Gabapentin binds with high-affinity to α2δ subunit of voltage-activated calcium channels; precise mechanism unknown."},{"drug_id":"buphenyl","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Buphenyl","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Aldose reductase, Histone deacetylase 1, Histone deacetylase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"radicava","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Radicava","company_name":"Shanghai Auzone Biological Technology Co., Ltd.","drug_phase":"marketed","molecular_target":"Polyunsaturated fatty acid lipoxygenase ALOX15","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"taurursodiol","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Relyvrio","generic_name":"TAURURSODIOL","company_name":"Amylyx","drug_phase":"marketed","molecular_target":"Phospholipase A2","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Relyvrio works by inhibiting the enzyme phospholipase A2, which is involved in the breakdown of lipids in the brain."},{"drug_id":"edaravone","indication_name":"Amyotrophic lateral sclerosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Radicava","generic_name":"EDARAVONE","company_name":"Kk Bcj-94","drug_phase":"marketed","molecular_target":"","drug_class":"edaravone","quality_score":51,"revenue":null,"mechanism":"Radicava works by scavenging free radicals and reducing oxidative stress in the body."}],"pipeline":[{"drug_id":"cromolyn-sodium","indication_name":"Amyotrophic Lateral Sclerosis (ALS)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CROMOLYN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"Mast cells","drug_class":"Mast cell stabilizer","quality_score":30,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":8,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT06209515","title":"Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61292,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT04328675","title":"Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China","phase":"","overall_status":"UNKNOWN","enrollment_count":4752,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT06201650","title":"Neurofilament Light Chain in Amyotrophic Lateral Sclerosis","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04454892","title":"Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04961450","title":"Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06578195","title":"ASSESS ALL ALS Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","has_results":false},{"nct_id":"NCT04885374","title":"China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Dongzhimen Hospital, Beijing","has_results":false},{"nct_id":"NCT03233646","title":"Retinal Imaging in Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05852405","title":"Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Ambulanzpartner Soziotechnologie APST GmbH","has_results":false},{"nct_id":"NCT06885918","title":"ALS Research Collaborative","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"ALS Therapy Development Institute","has_results":false},{"nct_id":"NCT06828523","title":"Assessing Perceptual Effects of Interactive Tasks","phase":"NA","overall_status":"RECRUITING","enrollment_count":1300,"lead_sponsor_name":"Penn State University","has_results":false},{"nct_id":"NCT07235111","title":"Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Ospedale Policlinico San Martino","has_results":false},{"nct_id":"NCT05119387","title":"Genetic Study of Amyotrophic Lateral Sclerosis in Norway","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Sykehuset Telemark","has_results":false},{"nct_id":"NCT06147843","title":"French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT06539169","title":"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT04819555","title":"Frequency of SOD1 and C9orf72 Gene Mutations in French ALS","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT07233148","title":"Healing ALS Registry Observational Study (HAROS)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Healing Advocates Registry and Ministry","has_results":false},{"nct_id":"NCT05892822","title":"Amyotrophic Lateral Sclerosis Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"yilong Wang","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT05137665","title":"Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Target ALS Foundation, Inc.","has_results":false},{"nct_id":"NCT04715399","title":"UPenn Observational Research Repository on Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07454733","title":"Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Trustees of Dartmouth College","has_results":false},{"nct_id":"NCT03516994","title":"Reducing Disparities in the Quality of Advance Care Planning for Older Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":790,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT01950910","title":"Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)","phase":"","overall_status":"TERMINATED","enrollment_count":766,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT02496767","title":"Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT07202494","title":"Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT05021536","title":"Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":664,"lead_sponsor_name":"Amylyx Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT05104710","title":"Intermuscular Coherence as a Biomarker for ALS","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06596746","title":"Neurodegenerative Diseases Progression Markers (MARKERS-NDD)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Casa di Cura San Raffaele Cassino","has_results":false},{"nct_id":"NCT06581861","title":"PREVENT ALL ALS Study","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","has_results":false},{"nct_id":"NCT04104373","title":"The Ontario Neurodegenerative Disease Research Initiative","phase":"","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"Ontario Neurodegeneration Disease Research Initiative","has_results":false},{"nct_id":"NCT00868166","title":"Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":512,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06418646","title":"Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT07400393","title":"Healey ALS MyMatch Common Screening Protocol","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03505021","title":"Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":496,"lead_sponsor_name":"Orion Corporation, Orion Pharma","has_results":true},{"nct_id":"NCT04944784","title":"A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":489,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT03160898","title":"A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT07467187","title":"Invasive Home Ventilation in Denmark","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT01160367","title":"Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life","phase":"NA","overall_status":"COMPLETED","enrollment_count":431,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT07325591","title":"Efficacy and Safety of Tazbentetol in ALS Participants","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":430,"lead_sponsor_name":"Spinogenix","has_results":false},{"nct_id":"NCT05193994","title":"Triumeq in Amyotrophic Lateral Sclerosis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":419,"lead_sponsor_name":"Macquarie University, Australia","has_results":false},{"nct_id":"NCT07174492","title":"Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":412,"lead_sponsor_name":"AB Science","has_results":false},{"nct_id":"NCT05663008","title":"Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Dublin, Trinity College","has_results":false},{"nct_id":"NCT06280079","title":"Ultra-high-caloric, Fatty Diet in ALS","phase":"NA","overall_status":"RECRUITING","enrollment_count":392,"lead_sponsor_name":"University of Ulm","has_results":false},{"nct_id":"NCT04248465","title":"An Efficacy and Safety Study of Ravulizumab in ALS Participants","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":382,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}